The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The current study describes the impact of particle size and/or molecular targeting (epidermal growth factor, EGF) on the in vivo transport of block copolymer micelles (BCMs) in athymic mice bearing human breast cancer xenografts that express differential levels of EGF receptors (EGFR). BCMs with diameters of 25 nm (BCM-25) and 60 nm (BCM-60) were labeled with indium-111 ((111)In) or a fluorescent probe to provide a quantitative and qualitative means of evaluating their whole body, intratumoral, and subcellular distributions. BCM-25 was found to clear rapidly from the plasma compared to BCM-60, leading to an almost 2-fold decrease in their total tumor accumulation. However, the tumoral clearance of BCM-25 was delayed through EGF functionalization, enabling the targeted BCM-25 (T-BCM-25) to achieve a comparable level of total tumor deposition as the nontargeted BCM-60 (NT-BCM-60). Confocal fluorescence microscopy combined with MATLAB analyses revealed that NT-BCM-25 diffuses further away from the blood vessels (D(mean) = 42 +/- 9 microm) following extravasation, compared to NT-BCM-60 which mainly remains in the perivascular regions (D(mean) = 23 +/- 4 microm). The introduction of molecular targeting imposes the "binding site barrier" effect, which retards the tumor penetration of T-BCM-25 (D(mean) = 29 +/- 7 microm, p < 0.05). The intrinsic nuclear translocation property of EGF/EGFR leads to a significant increase in the nuclear uptake of T-BCM-25 in vitro and in vivo via active transport. Overall, these results highlight the need to consider multiple design parameters in the development of nanosystems for delivery of anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some previous studies, it was shown that sizes from 50 nm–100 nm are effective in preclinical models, suggesting ideal particle size distribution is necessary for efficacy of polymeric micelles [253, 254].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [254]
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Self-citationMicellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Research works printed but not linked: 6
- Yokota T., 1992, Cancer Res., 52, 3402
- Amiji, M. M.Nanotechnology for cancer therapy;CRC/Taylor & Francis:Boca Raton, 2007; p817,[8] of plates.
- Yuan F., 1995, Cancer Res., 55, 3752
- Juweid M., 1992, Cancer Res., 52, 5144
- Thurber G. M., 2008, Trends Pharmacol. Sci., 29, 57
- Costantini D. L., 2008, Cancer Biother. Radiopharm., 23, 3
Cited by
Items 201–300 of 348
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model
Zalba, S., Contreras, A. M., Merino, M., Navarro, I., de Ilarduya, C. T., Trocóniz, I. F., Koning, G., & Garrido, M. J. (2016) · Nanomedicine · doi:10.2217/nnm.15.208 · Cited by 26
Xue, F., Dixon, H., Glen‐Ravenhill, H., Karaosmanoglu, S., Li, Q., Yan, L., & Chen, X. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900093 · Cited by 29
Grazú, V., Moros, M., & Sánchez‐Espinel, C. (2012) · Frontiers of nanoscience · doi:10.1016/b978-0-12-415769-9.00014-5 · Cited by 36
89Zr‐ and Fe‐Labeled Polymeric Micelles for Dual Modality PET and T1‐Weighted MR Imaging
Starmans, L. W. E., Hummelink, M. A. P. M., Rossin, R., Kneepkens, E., Lamerichs, R. M. J. N., Donato, K., Nicolay, K., & Grüll, H. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500414 · Cited by 27
Prasad, A. G., Nair, R., Bhatavdekar, O., Howe, A. K., Salerno, D., Sempkowski, M., Josefsson, A., Pacheco‐Torres, J., Bhujwalla, Z. M., Gabrielson, K. L., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05406-z · Cited by 24
Stras, S., Holleran, T. J., Howe, A. K., & Sofou, S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00439 · Cited by 25
Einen, C., Snipstad, S., Wesche, H. F., Nordlund, V., Devold, E. J., Amini, N., Hansen, R., Sulheim, E., & Davies, C. D. L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.037 · Cited by 27
Synthesis and Characterization of Anti-EGFR Fluorescent Nanoparticles for Optical Molecular Imaging
Chan, L. W., Wang, Y.-N., Lin, L. Y., Upton, M. P., Hwang, J. H., & Pun, S. H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300355y · Cited by 24
Saranya, J. D., Saminathan, P., Ankireddy, S. R., Shaik, M. R., Khan, M., Khan, M., & Shaik, B. (2023) · Biomedicines · doi:10.3390/biomedicines11020531 · Cited by 25
The holistic 3M modality of drug delivery nanosystems for cancer therapy
Sun, J., Luo, C., Wang, Y., & He, Z. (2012) · Nanoscale · doi:10.1039/c2nr32867d · Cited by 27
Lu, H. D., Wilson, B. K., Lim, T. L., Heinmiller, A., & Prud’homme, R. K. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00645 · Cited by 24
Štaka, I., Cadete, A., Surikutchi, B. T., Abuzaid, H., Bradshaw, T. D., Alonso, M. J., & Marlow, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.070 · Cited by 26
Stras, S., Howe, A. K., Prasad, A. G., Salerno, D., Bhatavdekar, O., & Sofou, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00812 · Cited by 24
Lepeltier, É., Bourgaux, C., Maksimenko, A., Meneau, F., Rosilio, V., Śliwiński, É., Zouhiri, F., Desmaële, D., & Couvreur, P. (2014) · Langmuir · doi:10.1021/la5007132 · Cited by 23
Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer
Bhattacharya, S. (2020) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892815666201221121859 · Cited by 32
Overview of nanogel and its applications
Ghaywat, S. D., Mate, P. S., Parsutkar, Y. M., Chandimeshram, A. D., & Umekar, M. J. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.16.1.0196 · Cited by 31
Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer
Bistrović, A., Melle, F., Linnane, E., González-López, C., Ahmed, I., Parshad, B., Franck, C. O., Rahmoune, H., Richards, F. M., Muñoz‐Espín, D., et al. (2022) · Nanoscale · doi:10.1039/d2nr00864e · Cited by 24
Duan, S., Sun, F., Qiao, P., Zhu, Z., Geng, M., Gong, X., Li, Y., & Yao, H. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01179 · Cited by 23
Potential drug delivery nanosystems for improving tumor penetration
Peng, F., Li, R., Zhang, F., Qin, L., Ling, G., & Zhang, P. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.04.009 · Cited by 23
Core–shell nanocarriers for cancer therapy. Part I: biologically oriented design rules
d’Angelo, I., Conte, C., Miro, A., Quaglia, F., & Ungaro, F. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.868881 · Cited by 22
Nanoparticles for tumor targeting
Jiang, T., Jin, K., Liu, X., & Pang, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101914-6.00008-9 · Cited by 30
Yang, C., Huang, S., Jia, T., Peng, Y., Wei, X., & Wang, M. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00324 · Cited by 20
Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique
Lebreton, V., Kaeokhamloed, N., Vasylaki, A., Hilairet, G., Mellinger, A., Bejaud, J., Saulnier, P., Lagarce, F., Gattacceca, F., Legeay, S., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.057 · Cited by 21
Treg Cells As Potential Cellular Targets for Functionalized Nanoparticles in Cancer Therapy
Jonuleit, H., Bopp, T., & Becker, C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0197 · Cited by 21
Liu, M., Luo, X., Qiu, Q., Kang, L., Li, T., Ding, J., Xiong, Y., Zhao, Z., Zan, J., Chang, C., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00687 · Cited by 21
Gong, M., Zhang, Q., Zhao, Q., Zheng, J., Li, Y., Wang, S., & Yuan, Y. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1618420 · Cited by 21
Next‐Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions
Fletcher, N. L., Kempe, K., & Thurecht, K. J. (2020) · Macromolecular Rapid Communications · doi:10.1002/marc.202000319 · Cited by 24
Takikawa, M., Fujisawa, M., Yoshino, K., & Takeoka, S. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s267638 · Cited by 23
Rad, A. T., Hargrove, D., Daneshmandi, L., Ramsdell, A. K., Lü, X., & Nieh, M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100080 · Cited by 18
Cerqueira, R., Domingues, C., Veiga, F., Jarak, I., & Figueiras, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147577 · Cited by 20
Khor, S. Y., Hu, J., McLeod, V. M., Quinn, J. F., Porter, C. J. H., Whittaker, M. R., Kaminskas, L. M., & Davis, T. P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.038 · Cited by 21
Kang, S., Wang, Y., Xu, X., Navarro-Comes, E., Tichauer, K. M., & Liu, J. T. C. (2017) · Journal of Biophotonics · doi:10.1002/jbio.201700246 · Cited by 19
Cisplatin and paclitaxel co-delivery nanosystem for ovarian cancer chemotherapy
Wang, Q., Wu, C., Li, X., Yang, D., & Shi, L. (2021) · Regenerative Biomaterials · doi:10.1093/rb/rbab015 · Cited by 19
Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue
Durymanov, M. O., Slastnikova, T. A., Kuzmich, A. I., Khramtsov, Y. V., Ulasov, A. V., Rosenkranz, A. A., Egorov, S. Y., Sverdlov, E. D., & Sobolev, A. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.076 · Cited by 18
Yang, Y. L., & Qiu, L. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.04.012 · Cited by 18
Mixed micelles as drug delivery nanocarriers
Sobczyński, J., & Chudzik-Rząd, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00009-0 · Cited by 19
Manipulating dynamic tumor vessel permeability to enhance polymeric micelle accumulation
Inoue, Y., Matsumoto, Y., Toh, K., Miyano, K., Cabral, H., Igarashi, K., Iwasaki, S., Kataoka, K., & Yamasoba, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.063 · Cited by 22
Liu, S., Shen, C., Jiang, D., Qian, C., Yang, Z., Wang, J., & Ye, W. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100429 · Cited by 18
Time-sequenced drug delivery approaches towards effective chemotherapeutic treatment of glioma
Li, M., Luo, Z. Y., Xia, Z., Shen, X., & Cai, K. (2017) · Materials Horizons · doi:10.1039/c7mh00342k · Cited by 19
Zhang, J., Liu, J., Zhao, Y., Wang, G., & Zhou, F. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.945417 · Cited by 17
Simpson, J. D., Ediriweera, G. R., Howard, C. B., Fletcher, N. L., Bell, C. A., & Thurecht, K. J. (2019) · Biomaterials Science · doi:10.1039/c9bm00957d · Cited by 17
Ramamurthy, R., Mehta, C. H., & Nayak, U. Y. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03109-z · Cited by 16
Shuhendler, A. J., Prasad, P., Cai, P., Hui, K. K., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.01.005 · Cited by 16
Skupin-Mrugalska, P., Elvang, P. A., & Brandl, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910456 · Cited by 15
Nanogel: Types, Methods of Preparation, Limitation, Evaluation and Application – A Systematic Review
Srivastava, S., Saha, S., & Jakhmola, V. (2023) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.13.4.77 · Cited by 15
Zhou, Z., Zhang, J., Chen, Q., Luo, Y., Xu, F., & Chen, Y. (2020) · Macromolecular Bioscience · doi:10.1002/mabi.202000291 · Cited by 15
Glatiramer acetate enhances tumor retention and innate activation of immunostimulants
Pressnall, M. M., Huang, A., Groer, C. E., Huayamares, S. G., Forrest, M. L., & Berkland, C. J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120812 · Cited by 15
Li, Y., Yu, H., Sun, H. Y., Liu, J., Tang, Z., Wang, D., Yu, L.-Y., & Chen, X. (2015) · Chinese Journal of Polymer Science · doi:10.1007/s10118-015-1624-0 · Cited by 15
Development of Pharmaceutically Adapted Mesoporous Silica Nanoparticles Platform
Meng, H., Xue, M., Zink, J. I., & Nel, A. E. (2012) · The Journal of Physical Chemistry Letters · doi:10.1021/jz300021x · Cited by 15
Development and Application of a Novel Model System to Study “Active” and “Passive” Tumor Targeting
Mukherjee, A., Kumar, B., Hatano, K., Russell, L. M., Trock, B. J., Searson, P. C., Meeker, A. K., Pomper, M. G., & Lupold, S. E. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0051 · Cited by 16
Kuo, P.-H., Teng, Y.-H., Cin, A.-L., Han, W., Huang, P.-W., Wang, L. H.-C., Chou, Y., Yang, J., Tseng, Y., Kao, M.-H., et al. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1745326 · Cited by 14
Sub-100 nm carriers by template polymerization for drug delivery applications
Hashim, P. K., & Abdrabou, S. S. M. A. (2024) · Nanoscale Horizons · doi:10.1039/d3nh00491k · Cited by 16
Brundel, D. H. S., Feeney, O. M., Nowell, C. J., Suys, E. J. A., Gracia, G., Kaminskas, L. M., McIntosh, M. P., Kang, D. W., & Porter, C. J. H. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0433 · Cited by 14
Nano-size Polymers via Precipitation of Polymer Solutions
Dwivedi, P., Karumbaiah, K. M., & Das, R. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-39715-3_9 · Cited by 14
Zhu, A., Sha, H., Su, S., Chen, F., Wei, J., Meng, F., Yang, Y., Du, J., Shao, J., Ji, F.-Z., et al. (2018) · PubMed · Cited by 13
Marecki, E. K., Oh, K. W., Knight, P. R., & Davidson, B. A. (2024) · Biomicrofluidics · doi:10.1063/5.0201465 · Cited by 15
Demirci, Z., İşlek, Z., Siginc, H. I., Sahin, F., Üçışık, M. H., & Bolat, Z. B. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105958 · Cited by 12
Multifunctional Enveloped Nanodevices (MENDs)
Sato, Y., Nakamura, T., Yamada, Y., Akita, H., & Harashima, H. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00006-7 · Cited by 15
Targeted drug delivery for cancer therapy
Stirland, D. L., Nichols, J. W., Denison, T. A., & Bae, Y. H. (2013) · Elsevier eBooks · doi:10.1533/9780857096760.1.31 · Cited by 12
Liu, Q., Tian, X., Gong, K., Qian, R., & Shen, S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00889 · Cited by 11
He, L., Meng, F., Chen, R., Qin, J., Sun, M., Fan, Z., & Du, J. (2024) · JACS Au · doi:10.1021/jacsau.4c00849 · Cited by 12
Imaging tumour distribution of a polymeric drug delivery platform in vivo by PET‐MRI
Puttick, S. G., Boase, N. R. B., Blakey, I., & Thurecht, K. J. (2014) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.4489 · Cited by 10
Makhlouf, A. I. A., Hajdu, I., Hartimath, S. V., Alizadeh, E., Wharton, K., Wasan, K. M., Badea, I., & Fonge, H. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00831 · Cited by 10
Self-citationEstimating Tumor Vascular Permeability of Nanoparticles Using an Accessible Diffusive Flux Model
Lim, M., Dharmaraj, V. L., Gong, B., Jung, B. T., & Xu, T. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01590 · Cited by 11
Russell, S., Nguyen, T. A., Bhagroo, S., Torres, C. R., Russell, M. J., & Alfano, R. R. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.1.015004 · Cited by 9
Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors
Chakravarti, A. R., Groer, C. E., Gong, H., Yudistyra, V., Forrest, M. L., & Berkland, C. J. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00897 · Cited by 10
Sahovaler, A., Valic, M. S., Townson, J. L., Chan, H. H. L., Zheng, M., Tzelnick, S., Mondello, T., Pener-Tessler, A., Eu, D., El‐Sayes, A., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0269 · Cited by 9
Sherwood, V., Silvio, D. D., & Bombelli, F. B. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_36 · Cited by 10
Zhang, T., Go, M. A., Stricker, C., Daria, V. R., & Tricoli, A. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01573h · Cited by 9
Radiolabeled block copolymer micelles for image-guided drug delivery
Ribeiro, E., Alho, I., Marques, F., Gano, L., Correia, I., Correia, J. D. G., Casimiro, S., Costa, L., Santos, I., & Fernandes, C. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.004 · Cited by 10
Tomalia, D. A., Nixon, L. S., & Hedstrand, D. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814527-2.00001-9 · Cited by 9
Immunostimulant Complexed With Polylysine Limits Transport and Maintains Immune Cell Activation
Pressnall, M. M., Huayamares, S. G., & Berkland, C. J. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.06.009 · Cited by 9
MacEwan, S. R., & Chilkoti, A. (2016) · Angewandte Chemie · doi:10.1002/ange.201610819 · Cited by 8
Mass Transport via Cellular Barriers and Endocytosis
Ferrati, S., Streiff, A. K., Srinivasan, S., Alexander, J. F., Bhargava, N., Peters, A. M., Song, N. E., Tasciotti, E., Godin, B., Ferrari, M., et al. (2011) · Fundamental biomedical technologies · doi:10.1007/978-94-007-1248-5_1 · Cited by 8
FUNCTIONALIZED POLYMERIC NANOPARTICLES: A NOVEL TARGETED APPROACH FOR ONCOLOGY CARE
Raikar, P., & Dandagi, P. M. (2021) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2021v13i6.42714 · Cited by 8
Lv, J., Xu, Y., Huang, Y., Yu, H., & Tang, Z. (2022) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202200065 · Cited by 8
In vivo Monitoring of Organ-Selective Distribution of CdHgTe/SiO2 Nanoparticles in Mouse Model
Chen, H., Cui, S., Tu, Z., Gu, Y., & Chi, X. (2011) · Journal of Fluorescence · doi:10.1007/s10895-011-1005-1 · Cited by 8
Gene Delivery into Cells and Tissues
Duvall, C. L., Prokop, A., Gersbach, C. A., & Davidson, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00035-5 · Cited by 10
Curry, S. D., Bower, B. M., Saemundsson, S. A., Goodwin, A. P., & Cha, J. N. (2025) · Nanoscale Advances · doi:10.1039/d4na00823e · Cited by 8
Yu, H., Tang, Z., Zhang, D., Song, W., Duan, T., Gu, J., & Chen, X. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500040 · Cited by 9
Murjan, S., Saeedi, S., & Nabid, M. R. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1742147 · Cited by 7
Huang, W., Zhang, L., Sun, J., Sun, Y., Gong, L., Ge, S., Wei, X., & Gao, W. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301890 · Cited by 6
A New Type of Nanogel Carrier based on Mixed Pluronic Loaded with Low-Dose Antitumor Drugs
Yin, M., Su, Z., Cui, B., Han, Y., Dai, H., & Yu, X. (2019) · Journal of Wuhan University of Technology-Mater Sci Ed · doi:10.1007/s11595-019-2144-5 · Cited by 6
Gene delivery into cells and tissues
Nelson, C. E., Duvall, C. L., Prokop, A., Gersbach, C. A., & Davidson, J. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00030-7 · Cited by 9
Gulin-Sarfraz, T., Pryazhnikov, E., Zhang, J., Khiroug, L. S., & Rosenholm, J. M. (2019) · Materials Today Bio · doi:10.1016/j.mtbio.2019.100010 · Cited by 6
Liu, B., Liu, Z., Wang, P., Zhang, Y., He, H., Yin, T., Gou, J., & Tang, X. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110229 · Cited by 5
pH-responsive polymers: classification, response mode, properties and biomedical applications
Wang, D., Yao, H., Ye, J., Wang, Z., Cong, H., & Yu, B. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.168589 · Cited by 19
Docetaxel-loaded block copolymer micelles labeled with 188Re for combined radiochemotherapy
Ribeiro, E., Marques, F., Gano, L., Correia, J. D. G., Santos, I., & Fernandes, C. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101898 · Cited by 5
Influence of Hydrophobic Chains in Nanocarriers on Antitumor Efficacy of Docetaxel Nanoparticles
Dong, Z., Shen, Y., Zhao, S., Wang, X., Han, M., Zhao, N., Ao, H., & Guo, Y. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01228 · Cited by 5
Long-Circulating Therapies for Cancer Treatment
Movassaghian, S., & Torchilin, V. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416603-5.00018-3 · Cited by 8
Quaglia, F., & Sortino, S. (2016) · Lecture notes in chemistry · doi:10.1007/978-3-319-31671-0_9 · Cited by 4
Burrer, C. M., Auburn, H., Wang, X., Luo, J., Abulwerdi, F. A., Nikolovska‐Coleska, Z., & Chan, G. C. T. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.027 · Cited by 4
Wu, Y., Ieong, H., Wang, W., Wu, C., Lu, A., Pan, X., & Huang, Z. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111944 · Cited by 7
Wu, L., Shen, S., Qian, C., Wu, N., Qiu, X., & Hou, H. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02080h · Cited by 3
Progress in nanotechnology-based targeted cancer treatment
Khan, S. A., Kilor, V. A., Singhavi, D. J., & Patil, K. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89839-3.00007-5 · Cited by 5
Targeting strategies using PLGA nanoparticles for efficient drug delivery
Sharma, P., Kaur, N., & Shanavas, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91215-0.00016-9 · Cited by 4
Multifunctional nanoparticles—cost versus benefit of adding targeting and imaging capabilities
Sarma, A., & Das, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821712-2.00004-9 · Cited by 3
Travis, A. R., Liau, V. A., Agrawal, A. C., & Cliffel, D. E. (2017) · Journal of Nanoparticle Research · doi:10.1007/s11051-017-4041-1 · Cited by 3
Nanomedicine in Cancer Stem Cell Therapy
Gupta, P. K., Gunasekaran, D., Misra, R., Gupta, S., & Verma, R. S. (2020) · Springer eBooks · doi:10.1007/978-981-32-9898-9_4 · Cited by 4
Tumor‐Targeted Nanoparticles: State‐of‐the‐Art and Remaining Challenges
Bajaj, G., & Yeo, Y. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse488 · Cited by 5
Metadata
- Authors
- Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Allen, Christine
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-05-26
- Volume
- 7
- Issue
- 4
- Pages
- 1195-1208
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1985006200
- Cited by
- 349
- References
- 46
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 18 · 2023: 15 · 2022: 10 · 2021: 24 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 35 · 2016: 26 · 2015: 24 · 2014: 28 · 2013: 26 · 2012: 24
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polymeric nanoparticles, block copolymer micelles, particle size, molecular targeting, epidermal growth factor, EGFR, intratumoral distribution, subcellular localization, tumor penetration, nuclear translocation, tumor xenografts, breast cancer, indium-111 labeling, nanoparticle clearance
- MeSH terms
- Animals, Breast Neoplasms, Drug Carriers, Epidermal Growth Factor, Female, Humans, Mice, Nude, Particle Size, Polymers, Microscopy, Confocal, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Nanoparticles, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.